R1	Subsumes Arg1:T2 Arg2:T3	
*	OR T4 T5 T6
R2	Has_value Arg1:T2 Arg2:T4	
R3	Has_value Arg1:T10 Arg2:T11	
R4	Has_temporal Arg1:T8 Arg2:T9	
*	OR T8 T10
R5	Has_value Arg1:T12 Arg2:T14	
R6	Has_multiplier Arg1:T13 Arg2:T15	
R7	Has_value Arg1:T16 Arg2:T17	
R8	Has_value Arg1:T18 Arg2:T19	
R9	Has_value Arg1:T20 Arg2:T21	
*	OR T16 T18 T20
R10	Has_value Arg1:T22 Arg2:T23	
R11	Has_value Arg1:T25 Arg2:T26	
R12	Has_qualifier Arg1:T29 Arg2:T30	
R13	Has_value Arg1:T32 Arg2:T33	
R14	AND Arg1:T34 Arg2:T35	
T1	Procedure 0 13	Re-transplant
T2	Measurement 34 57	panel reactive antibody
T3	Measurement 59 62	PRA
T4	Value 64 85	equal to or above 50%
T5	Value 87 94	class I
T6	Value 98 106	class II
T8	Condition 109 132	Acute rejection episode
T9	Temporal 140 152	last 30 days
T10	Measurement 177 191	Banff criteria
T11	Value 165 169	> 2A
T12	Measurement 194 197	GFR
T14	Value 205 216	< 40 ml/min
T13	Condition 219 230	Proteinuria
T15	Multiplier 231 240	> 0,5 g/l
T16	Measurement 243 253	Hemoglobin
T17	Value 254 262	< 10 g/l
T18	Measurement 270 280	leucocytes
T19	Value 281 296	< 4000 cels/mm3
T20	Measurement 304 313	platelets
T21	Value 314 332	< 150.000 cels/mm3
T22	Measurement 335 348	Triglycerides
T23	Value 349 360	> 500 mg/dl
T24	Drug 384 391	fibrate
T25	Measurement 394 411	Cholesterol total
T26	Value 412 423	> 300 mg/dl
T27	Drug 447 453	statin
T28	Condition 456 477	Hepatic abnormalities
T29	Condition 492 507	periphery edema
T30	Qualifier 480 491	Significant
T31	Condition 510 533	Pulmonary abnormalities
T32	Procedure 537 549	breast x-ray
T33	Value 550 563	abnormalities
T34	Condition 566 583	Hyper sensibility
T35	Drug 587 596	sirolimus
